429 related articles for article (PubMed ID: 25337215)
41. Clonal origin of Epstein-Barr virus (EBV)-infected T/NK-cell subpopulations in EBV-positive T/NK-cell lymphoproliferative disorders of childhood.
Ohga S; Ishimura M; Yoshimoto G; Miyamoto T; Takada H; Tanaka T; Ohshima K; Ogawa Y; Imadome K; Abe Y; Akashi K; Hara T
J Clin Virol; 2011 May; 51(1):31-7. PubMed ID: 21377409
[TBL] [Abstract][Full Text] [Related]
42. Differential cellular targets of Epstein-Barr virus (EBV) infection between acute EBV-associated hemophagocytic lymphohistiocytosis and chronic active EBV infection.
Kasahara Y; Yachie A; Takei K; Kanegane C; Okada K; Ohta K; Seki H; Igarashi N; Maruhashi K; Katayama K; Katoh E; Terao G; Sakiyama Y; Koizumi S
Blood; 2001 Sep; 98(6):1882-8. PubMed ID: 11535525
[TBL] [Abstract][Full Text] [Related]
43. Epstein-Barr Virus (EBV)-induced B-cell Lymphoproliferative Disorder Mimicking the Recurrence of EBV-associated Hemophagocytic Lymphohistiocytosis.
Yatsushiro Y; Nishikawa T; Saito A; Nakazawa Y; Imadome KI; Nakagawa S; Kodama Y; Okamoto Y; Kanegane H; Kawano Y
J Pediatr Hematol Oncol; 2019 Jan; 41(1):e44-e46. PubMed ID: 29324572
[TBL] [Abstract][Full Text] [Related]
44. Resolution of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis associated with rapid immune reconstruction after a single course of CHOP therapy.
Chikagawa Y; Hikishima K; Mizumaki H; Sugimori C; Nakagishi Y; Yachie A; Nakao S
Int J Hematol; 2020 Dec; 112(6):889-893. PubMed ID: 32725606
[TBL] [Abstract][Full Text] [Related]
45. Infection of T lymphocytes in Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in children of non-Asian origin.
Beutel K; Gross-Wieltsch U; Wiesel T; Stadt UZ; Janka G; Wagner HJ
Pediatr Blood Cancer; 2009 Aug; 53(2):184-90. PubMed ID: 19353621
[TBL] [Abstract][Full Text] [Related]
46. Prognostic factors of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in children: report of the Japan Histiocytosis Study Group.
Kogawa K; Sato H; Asano T; Ohga S; Kudo K; Morimoto A; Ohta S; Wakiguchi H; Kanegane H; Oda M; Ishii E
Pediatr Blood Cancer; 2014 Jul; 61(7):1257-62. PubMed ID: 24535916
[TBL] [Abstract][Full Text] [Related]
47. A novel animal model of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in humanized mice.
Sato K; Misawa N; Nie C; Satou Y; Iwakiri D; Matsuoka M; Takahashi R; Kuzushima K; Ito M; Takada K; Koyanagi Y
Blood; 2011 May; 117(21):5663-73. PubMed ID: 21467545
[TBL] [Abstract][Full Text] [Related]
48. Acquired hemophilia A associated with Epstein-Barr-virus-associated T/natural killer-cell lymphoproliferative disease: A case report.
Yamamoto M; Shindo M; Sumi C; Igarashi S; Saito T; Tsukada N; Toki Y; Hatayama M; Inamura J; Sato K; Mizukami Y; Torimoto Y; Okumura T
Medicine (Baltimore); 2021 Apr; 100(16):e25518. PubMed ID: 33879690
[TBL] [Abstract][Full Text] [Related]
49. A Case of severe mosquito bite allergy complicated by fatal hemophagocytic lymphohistiocytosis.
Dupuy E; Afifi L; Jonas SJ; Cheng CE; Hogeling M
Pediatr Dermatol; 2022 May; 39(3):443-446. PubMed ID: 35322460
[TBL] [Abstract][Full Text] [Related]
50. [The understanding of Epstein-Barr virus associated lymphoproliferative disorder].
Zhou XG; Zhang YL; Xie JL; Huang YH; Zheng YY; Li WS; Chen H; Liu F; Pan HX; Wei P; Wang Z; Hu YC; Yang KY; Xiao HL; Wu MJ; Yin WH; Mei KY; Chen G; Yan XC; Meng G; Xu G; Li J; Tian SF; Zhu J; Song YQ; Zhang WJ
Zhonghua Bing Li Xue Za Zhi; 2016 Dec; 45(12):817-821. PubMed ID: 28056294
[TBL] [Abstract][Full Text] [Related]
51. Spontaneous Recovery of Hemophagocytic Lymphohistiocytosis Due to Primary Epstein-Barr Virus Infection in an Adult Patient.
Matsuo Y; Iwanami K; Hiraoka E; Oda R
Am J Case Rep; 2021 Oct; 22():e933272. PubMed ID: 34657119
[TBL] [Abstract][Full Text] [Related]
52. Fatal hemophagocytic syndrome in a patient with a previously well-controlled asymptomatic HIV infection after EBV reactivation.
Thoden J; Rieg S; Venhoff N; Wennekes V; Schmitt-Graeff A; Wagner D; Kern WV
J Infect; 2012 Jan; 64(1):110-2. PubMed ID: 21888928
[TBL] [Abstract][Full Text] [Related]
53. Nodal EBV-positive polymorphic B cell lymphoproliferative disorder with plasma cell differentiation: clinicopathological analysis of five cases.
Satou A; Tabata T; Suzuki Y; Sato Y; Tahara I; Mochizuki K; Oishi N; Takahara T; Yoshino T; Tsuzuki T; Nakamura S
Virchows Arch; 2021 May; 478(5):969-976. PubMed ID: 33169195
[TBL] [Abstract][Full Text] [Related]
54. EBV-HLH children with reductions in CD4+ T cells and excessive activation of CD8+ T cells.
Yang C; Zhu X; Zhang T; Ye Q
Pediatr Res; 2017 Dec; 82(6):952-957. PubMed ID: 28738028
[TBL] [Abstract][Full Text] [Related]
55. Allogeneic hematopoietic stem cell transplantation for Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disease in Japan.
Sato E; Ohga S; Kuroda H; Yoshiba F; Nishimura M; Nagasawa M; Inoue M; Kawa K
Am J Hematol; 2008 Sep; 83(9):721-7. PubMed ID: 18626884
[TBL] [Abstract][Full Text] [Related]
56. Fulminant EBV(+) T-cell lymphoproliferative disorder following acute/chronic EBV infection: a distinct clinicopathologic syndrome.
Quintanilla-Martinez L; Kumar S; Fend F; Reyes E; Teruya-Feldstein J; Kingma DW; Sorbara L; Raffeld M; Straus SE; Jaffe ES
Blood; 2000 Jul; 96(2):443-51. PubMed ID: 10887104
[TBL] [Abstract][Full Text] [Related]
57. Hematopoietic Bone Marrow Transplant to Treat Systemic EBV-positive T-cell Lymphoma of Childhood.
Manini N; Davidow K; Conard K; Powell J
J Pediatr Hematol Oncol; 2024 Mar; 46(2):e208-e211. PubMed ID: 38117087
[TBL] [Abstract][Full Text] [Related]
58. Epstein barr virus hemophagocytic lymphohistiocytosis related to rituximab use and immunopathogenetic insights.
Papageorgiou SG; Tsiodras S; Siakallis G; Bazani E; Spathis A; Poulakou G; Korkolopoulou P; Panayiotides I; Pappa V
Pathol Res Pract; 2016 Dec; 212(12):1194-1198. PubMed ID: 28340951
[TBL] [Abstract][Full Text] [Related]
59. Novel mouse xenograft models reveal a critical role of CD4+ T cells in the proliferation of EBV-infected T and NK cells.
Imadome K; Yajima M; Arai A; Nakazawa A; Kawano F; Ichikawa S; Shimizu N; Yamamoto N; Morio T; Ohga S; Nakamura H; Ito M; Miura O; Komano J; Fujiwara S
PLoS Pathog; 2011 Oct; 7(10):e1002326. PubMed ID: 22028658
[TBL] [Abstract][Full Text] [Related]
60. Treatment choice of immunotherapy or further chemotherapy for Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.
Shiraishi A; Ohga S; Doi T; Ishimura M; Takimoto T; Takada H; Miyamoto T; Abe Y; Hara T
Pediatr Blood Cancer; 2012 Aug; 59(2):265-70. PubMed ID: 22183955
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]